Schedule 13D ownership disclosure
ACURA PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 00509L703
Event date: 2015-03-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,112,126
- Percent of class
- 6.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-15-018152
- Form type
- SC 13D
- Filer
- ACURA PHARMACEUTICALS, INC
- CIK
- CIK 786947
- Filed
- Mar 09, 2015
- Reporting period
- Mar 02, 2015
- Description
- Schedule 13D beneficial ownership